Quantitative and reliable in vitro method combining scanning electron microscopy and image analysis for the screening

Gaël Grimandi1, Assem Soueidan, Abed Aktam Anjrini

  • 1Inserm, UMRS 791, Laboratoire d'ingénierie Ostéo-articulaire et dentaire (LIOAD), Univ Nantes, Faculté de chirurgie dentaire, F-44042 Nantes, France.

Insights

A new pit resorption assay quantifies osteoclast activity in bone diseases. Measuring resorbed surface area is the most relevant marker for assessing bone resorption, aiding in the development of new bone disease treatments.

Area of Science:

  • Bone biology and disease
  • Cellular and molecular mechanisms of bone remodeling

Background:

  • Increased osteoclast activity impairs bone remodeling in various bone diseases.
  • Existing drugs like bisphosphonates aim to inhibit osteoclast activity.
  • A sensitive assay is needed to quantify osteoclast function.

Purpose of the Study:

  • To develop and validate a quantitative pit resorption assay for measuring osteoclast activity.
  • To determine the most relevant metric for osteoclast activity: pit number or resorbed area.
  • To assess the assay's utility for screening bone modulators.

Main Methods:

  • Culturing rabbit bone cells rich in osteoclasts on dentin slices.
  • Quantifying resorption pits using scanning electron microscopy and image analysis.
  • Measuring both the number of resorption pits and the total resorbed surface area.

Main Results:

  • Resorption pits formed by 48 hours and increased up to 96 hours.
  • A strong correlation was observed between total resorbed area and pit number.
  • Resorbed surface area was identified as the most relevant marker of osteoclast activity.

Conclusions:

  • The developed pit resorption assay is reproducible and sensitive.
  • This quantitative method is valuable for screening osteoclast inhibitors.
  • The assay can be broadly applied to investigate bone modulators and bone disease mechanisms.

Related Concept Videos